Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Red5Lukeon Apr 03, 2019 1:38pm

85 Views

Post# 29577149

RE:RE:RE:Short term buying window

Wouldn't surprise me if we got an update on the SGLT2 clincial trial before we get the contract news release. Or I could see them tag in contract negotiation update (negotiations continue to finalize deal....blah blah) at the end of an SGLT2 update even.

Time will tell..... but hopefully that time isnt too long! Looks like we are already starting to bounce up a bit now. But like Putin noted lots of volume on German exchanges with similar shareprice. My thoughts are it is probably a buying op and news will arrive sooner than later.

Bullboard Posts

5 steps to mastering risk management in the stock market